Search

everythinglearnresearchcommunity

for

Search:↓

The hydrogel with a 1:3 ratio of hydroxyethyl cellulose to hyaluronic acid is effective for delivering drugs through the skin to treat acne.

Frontal fibrosing alopecia is linked to four genetic areas, especially the HLA-B*07:02 allele.

Minoxidil solution helps hair regrowth in alopecia areata, with 5% being more effective.

Ketoconazole shampoo improves hair growth and reduces oil similarly to minoxidil in male pattern hair loss.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Fetal skin cells from a cell bank heal wounds faster and with less scarring than adult cells.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

Stress increases certain chemicals in the skin and nerves, which might worsen skin conditions.

More research is needed to understand alopecia areata severity.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Squalene-based carriers improve delivery of a treatment to hair follicles for alopecia areata.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

HIV can cause unusual and severe skin problems that are hard to treat.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

Understanding the genetics of rare inherited ichthyosis syndromes is key for better treatments and genetic counseling.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

Botulinum toxin has potential for treating various skin conditions and improving wound healing.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

EVG staining is a valuable, simple, and cost-effective method for diagnosing various skin conditions in dermatopathology.

Itraconazole was effective in treating unusual M. canis infections in only one of two HIV-infected men.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

A fungal infection can look like a different scalp condition in teens, leading to wrong treatment until proper tests are done.

Stress in mice delays hair growth and treatments blocking substance P can partly reverse this effect.

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

Topical anthralin helped regrow hair in mice with a condition similar to human alopecia.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Baricitinib helped a woman with severe hair loss regrow almost all her hair without side effects.

Men with hair loss have more DNA changes in back-of-head hair follicles, possibly protecting them from thinning.